- Home
- DMO vs INO Comparison
DMO vs INO Comparison
Compare DMO & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DMO | INO |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.8M | 136.6M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | DMO | INO |
|---|---|---|
| Price | $11.56 | $1.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 49.6K | ★ 1.3M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 12.06% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14,751.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.00 | $1.30 |
| 52 Week High | $11.80 | $4.61 |
Technical Indicators
Market Signals| Indicator | DMO | INO |
|---|---|---|
| Relative Strength Index (RSI) | 29.60 | 43.48 |
| Support Level | $11.75 | $1.76 |
| Resistance Level | $11.68 | $2.10 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 2.11 | 51.28 |
Price Performance
Historical ComparisonAbout DMO Western Asset Mortgage Opportunity Fund Inc.
Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.